SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Witold X. Chmielewski, Christian Beste, Action control processes in autism spectrum disorder – Insights from a neurobiological and neuroanatomical perspective, Progress in Neurobiology, 2015, 124, 49

    CrossRef

  2. 2
    Donald C. Rojas, Katherine M. Becker, Lisa B. Wilson, Magnetic Resonance Spectroscopy Studies of Glutamate and GABA in Autism: Implications for Excitation-Inhibition Imbalance Theory, Current Developmental Disorders Reports, 2015, 2, 1, 46

    CrossRef

  3. 3
    Yeon Jung Lee, Soo Hyun Oh, Chanmin Park, Minha Hong, Ah Rah Lee, Hee Jeong Yoo, Chan Young Shin, Keun-Ah Cheon, Geon Ho Bahn, Advanced Pharmacotherapy Evidenced by Pathogenesis of Autism Spectrum Disorder, Clinical Psychopharmacology and Neuroscience, 2014, 12, 1, 19

    CrossRef

  4. 4
    Russell G. Port, Michael J. Gandal, Timothy P. L. Roberts, Steven J. Siegel, Gregory C. Carlson, Convergence of circuit dysfunction in ASD: a common bridge between diverse genetic and environmental risk factors and common clinical electrophysiology, Frontiers in Cellular Neuroscience, 2014, 8,

    CrossRef

  5. 5
    V. Kumar, T.C. Nag, U. Sharma, N.R. Jagannathan, S. Wadhwa, Differential effects of prenatal chronic high-decibel noise and music exposure on the excitatory and inhibitory synaptic components of the auditory cortex analog in developing chicks (Gallus gallus domesticus), Neuroscience, 2014, 269, 302

    CrossRef

  6. 6
    L Tebartz van Elst, S Maier, T Fangmeier, D Endres, G T Mueller, K Nickel, D Ebert, T Lange, J Hennig, M Biscaldi, A Riedel, E Perlov, Disturbed cingulate glutamate metabolism in adults with high-functioning autism spectrum disorder: evidence in support of the excitatory/inhibitory imbalance hypothesis, Molecular Psychiatry, 2014, 19, 12, 1314

    CrossRef

  7. 7
    Donald C. Rojas, The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment, Journal of Neural Transmission, 2014, 121, 8, 891

    CrossRef

  8. 8
    Daniel A. Rossignol, Richard E. Frye, The Use of Medications Approved for Alzheimer’s Disease in Autism Spectrum Disorder: A Systematic Review, Frontiers in Pediatrics, 2014, 2,

    CrossRef

  9. 9
    Donald C Rojas, Lisa B Wilson, γ-band abnormalities as markers of autism spectrum disorders, Biomarkers in Medicine, 2014, 8, 3, 353

    CrossRef

  10. 10
    C. Ecker, Pathobiology of Human Disease, 2014,

    CrossRef

  11. 11
    Martha R. Herbert, Cindy Sage, Autism and EMF? Plausibility of a pathophysiological link – Part I, Pathophysiology, 2013, 20, 3, 191

    CrossRef

  12. 12
    C. Ecker, W. Spooren, D. Murphy, Developing new pharmacotherapies for autism, Journal of Internal Medicine, 2013, 274, 4